Blinatumomab in Acute Lymphoblastic Leukemia

1 Views
administrator
administrator
06/15/23

In this segment, Dan Douer, MD, and Mark R Litzow, MD, describe the novel immunotherapy agent, blinatumomab.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next